Allergan introduces REFRESH OPTIVE MEGA-3 enhanced with flaxseed oil
New offering restores lipid layer and brings hydration to all three layers of tear film damaged by Dry Eye.
Allergan has launched the over-the-counter (OTC) artificial tear REFRESH OPTIVE MEGA-3, the latest innovation in the REFRESH portfolio that fortifies the lipid layer when Meibomian Gland Dysfunction (MGD) patients suffer from Dry Eye. MEGA-3 is formulated with flaxseed and castor oil, two natural, plant-based oils which protect tears from evaporating while nourishing the lipid layer damaged by Dry Eye and providing essential hydration to all three layers of the tear film. It's clinically proven to treat the signs and symptoms of Dry Eye.
"I recommend MEGA-3 for patients suffering from Dry Eye symptoms associated with MGD, who are looking for relief. In addition, MEGA-3 is specially formulated for stability, so no shaking is required -- just drop and go." said Milton M. Hom, OD, FAAO.
An estimated 25 million people in the US suffer from Dry Eye symptoms, including irritation, blurred vision, sensitivity to light, burning, stinging, dryness and excessive tearing. MEGA-3 also contains carboxymethylcellulose (CMC), an active lubricant found in all REFRESH OPTIVE formulas. This water-loving polymer, binds to epithelial cells to maintain moisture on the ocular surface for rapid on-eye comfort and long-lasting relief."As the innovators of the number one doctor-recommended brand of artificial tears1, we are pleased to expand our robust dry eye portfolio with REFRESH OPTIVE MEGA-3," said Herm Cukier, Senior Vice President, Eye Care. "Our REFRESH line of patented products offer patients a wide variety of options to treat their individual dry eye needs."
All OPTIVE products include the patented osmoprotectant formula that includes three compatible solutes -- glycerin, I-carnitine and erythritol -- all of which deliver added protection to the corneal epithelial cells against hypertonic stress. REFRESH OPTIVE MEGA-3 contains a fourth osmoprotectant, trehalose, for an advanced approach to treating Dry Eye symptoms.
MEGA-3 is available in 30-count single-use vials and can be found nationwide at various retail locations where OTC eye drops are sold.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance